Yintao D. Li
12 Middle Wulumuqi Road
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Beyond the P Value: A Systematic Framework for Interpreting Oncology Clinical Trials.
Journal: JCO precision oncology
Published: August 13, 2026
Real-world comparison of chemoimmunotherapy and chemotherapy alone in elderly patients (≥75 years) with extensive-stage small cell lung Cancer.
Journal: Future oncology (London, England)
Published: June 27, 2026
Development of a deep learning model based on computed tomography automatic segmentation to assist in selecting optimal time-to-surgery and dissected lymph node count for non-small cell lung cancer patients undergoing neoadjuvant immunotherapy and chemotherapy: a multicenter study.
Journal: Translational lung cancer research
Published: December 30, 2025
Role of metabolic reprogramming of cancer‑associated fibroblasts in tumor development and progression (Review).
Journal: International journal of oncology
Published: May 21, 2025
Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications.
Journal: Journal of hematology & oncology
Published: March 11, 2025
Efficacy of chemotherapy combined with immunotherapy in advanced lung adenocarcinoma harboring epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins) mutations: A retrospective comparative study.
Journal: Cancer pathogenesis and therapy
Published: March 03, 2025
Efficacy of Almonertinib Versus Osimertinib as the First-Line Treatment for Non-Small Cell Lung Cancer With EGFR L858R Mutation and Prognostic Analysis: A Retrospective Comparative Cohort Study.
Journal: Cancer medicine
Published: March 02, 2025
TRIM13 in situ engineering boosts anti-inflammatory capacity of CAR-Ms for liver fibrosis therapy.
Journal: Nature communications
Published: February 28, 2025
Last Updated: 09/26/2026